Oaktree Capital Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,667
Closed -$2.03M 258
2023
Q1
$2.03M Hold
6,667
0.02% 242
2022
Q4
$1.98M Hold
6,667
0.02% 277
2022
Q3
$1.94M Hold
6,667
0.02% 292
2022
Q2
$1.94M Hold
6,667
0.02% 284
2022
Q1
$1.95M Hold
6,667
0.02% 273
2021
Q4
$1.93M Hold
6,667
0.02% 257
2021
Q3
$1.94M Buy
+6,667
New +$1.94M 0.03% 198

Other funds holding XAGE

Oaktree Capital Management's XAGE Position: Q2 2023 in Review

Oaktree Capital Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2023, closing a stake of 6,667 shares — an estimated $2.03M sold.

Oaktree Capital Management first reported a position in XAGE in Q3 2021 and held it in 7 quarters. The position peaked at $2.03M in Q1 2023. 35 funds tracked by Wall St. Rank hold XAGE as of Q2 2023.

  • Oaktree Capital Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Oaktree Capital Management sold 6,667 Longevity Health Holdings, Inc. Common Stock shares in Q2 2023, an estimated $2.03M.
  • Oaktree Capital Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Oaktree Capital Management's Longevity Health Holdings, Inc. Common Stock position peaked at $2.03M in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2023.

Based on Oaktree Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.